Pragmatic clinical trial on efficacy of managing reduced iron stores on risk of clinically important events in older adults with heart failure and anemia (U01 Clinical Trial Required)
Funding Opportunity PA-19-230 from the NIH Guide for Grants and Contracts. This FOA invites applications for a pragmatic clinical trial to establish efficacy of managing reduced iron stores on risk of clinically important events in older adults with heart failure and anemia. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 28, 2019 Category: Research Source Type: funding
Notice of Intent to Fund a Strong Heart Study Phase VII Exam
Notice NOT-HL-19-687 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 27, 2019 Category: Research Source Type: funding
Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (UG3/UH3 Clinical Trial Optional)
Grants for projects that propose to test implementation research strategies for optimally and sustainably delivering evidence-based interventions to reduce or eliminate cardiovascular and/or pulmonary health disparities, and that promote and improve population health in high-burden communities. Geographic coverage: Nationwide -- National Institutes of Health, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - March 19, 2019 Category: American Health Source Type: funding
Notice of Special Interest (NOSI): Bold New Bioengineering Research for Heart, Lung, Blood and Sleep Disorders and Diseases
Notice NOT-HL-19-678 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 14, 2019 Category: Research Source Type: funding
Notice of Special Interest: SEARCH: Stimulating ExplorAtory Research on HIV/AIDS Contribution to Heart, Lung, Blood and Sleep Comorbidities (R01 - Clinical Trial Not Allowed)
Notice NOT-HL-19-677 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 14, 2019 Category: Research Source Type: funding
Good Health and Wellness in Indian Country
Grants for projects designed to reduce rates of death and disability from commercial tobacco use, diabetes, heart disease, and stroke and reduce the prevalence of obesity and other chronic disease risk factors and conditions in American Indian and Alaska Native communities. Geographic coverage: Nationwide -- Centers for Disease Control and Prevention, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - March 12, 2019 Category: American Health Source Type: funding
Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) - Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-20-004 from the NIH Guide for Grants and Contracts. The National Heart, Lung, and Blood Institute invites applications for a Research Coordinating Center (RCC) to support projects from RFA-HL-20-003 Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR), which will test late-stage (T4) implementation research strategies for optimally and sustainably delivering proven-effective, evidence-based multi-level interventions to reduce or eliminate cardiovascular and/or pulmonary health disparities, and that promote and improve populatio...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 11, 2019 Category: Research Source Type: funding
Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional)
Funding Opportunity RFA-HL-20-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement invites applications for projects that propose to test T4 implementation research strategies for delivering proven-effective, evidence-based community-level interventions for reducing or eliminating cardiovascular and/or pulmonary health disparities, and that promote and improve population health in high-burden communities. For the purpose of this FOA, T4 implementation research is defined as research to identify strategies to enhance sustainable uptake of proven-effective interventions in routine clinica...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 11, 2019 Category: Research Source Type: funding
Request for Information (RFI): Inviting Comments and Suggestions on the Potential Development of a Challenge Prize for Heart Failure Phenotyping
Notice NOT-HL-19-685 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 6, 2019 Category: Research Source Type: funding
Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States Including in Health Disparities Populations (U19 Clinical Trial not Allowed)
Funding Opportunity RFA-NS-19-012 from the NIH Guide for Grants and Contracts. The National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Aging (NIA) intend to publish a Funding Opportunity Announcement (FOA) to solicit applications for a large prospective clinical research study to determine the specific subsets of stroke events that predict cognitive impairment and dementia in post-stroke populations in the United States, including in health disparities populations, and what additional clinical factors and comorbidities along the AD/ADRD spectrum may causally synergize with stroke to...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 15, 2019 Category: Research Source Type: funding
Validating Human Stem Cell Cardiomyocyte Technology for Better Predictive Assessment of Drug-Induced Cardiac Toxicity (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-FD-19-002 from the NIH Guide for Grants and Contracts. Cardiovascular toxicity is a leading cause of drug attrition in drug development. Proarrhythmia, QT prolongation and Torsade de Point (TdP) contribute the most to this attrition and these outcomes drive the efforts spent to eliminate them from the drug discovery pipeline. Currently, these endpoints are evaluated through in vivo preclinical studies followed by a thorough-QT (TQT) study in the clinical phase. T FDA seeks new assays to replace non-clinical cardiotoxicity assessments. Specific interest is in assays based on human cells or materia...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 29, 2019 Category: Research Source Type: funding
NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
Funding Opportunity RFA-HL-20-012 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PD/PIs) who are currently PD/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrates their ability to make major contributions to heart, lung, blood and sleep (HLBS) research. The EIA is intended to support a research program, rather than a research project, by providing the...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 25, 2019 Category: Research Source Type: funding
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
Funding Opportunity RFA-HL-20-011 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI Outstanding Investigator Award (OIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PD/PIs) who are currently PD/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrates their ability to make major contributions to heart, lung, blood and sleep (HLBS) research. The OIA is intended to support a research program, rather than a research project, by providing ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 25, 2019 Category: Research Source Type: funding
Notice of Extension of the Response Date for NOT-HL-18-660 "Request for Information (RFI): Understanding the Health of Women and the Role of Sex/Gender in Mechanisms of Heart, Lung, Blood, and Sleep Diseases and Disorders"
Notice NOT-HL-19-672 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 18, 2019 Category: Research Source Type: funding
Notice of NHLBI Participation in PA-19-111 "Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)"
Notice NOT-HL-19-673 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 17, 2019 Category: Research Source Type: funding
